MTHFR genetics (especially C677T and A1298C variants) is often portrayed in lay circles as a major cause of fatigue, depression, thrombosis, or miscarriage. However, the scientific evidence is far more cautious: these variants reduce the activity of the methylenetetrahydrofolate reductase enzyme, which is involved in folate metabolism. Reduced activity can lead to elevated homocysteine levels when folate intake is low – a known risk factor for cardiovascular events. But: most carriers have no health issues, and evidence for direct causal links to the claimed conditions is weak or contradictory. Many direct-to-consumer tests overstate clinical relevance. Testing is only useful in the context of a medical workup for elevated homocysteine or specific risk factors. Routine supplementation with methylfolate is not evidence-based and may even carry risks. Bottom line: MTHFR is a prime example of the gap between mechanistic plausibility and clinical evidence.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-029cc2777a7f2b9c5ab9f724